METABOLIC SOLUTIONS DEV CO has a total of 27 patent applications. Its first patent ever was published in 2007. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and New Zealand. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AJAMI ALFRED M, LILLY ICOS LLC and SOLVAY PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | New Zealand | 4 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | Israel | 1 | |
#7 | Mexico | 1 | |
#8 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Colca Gerard R | 19 |
#2 | Kletzien Rolf F | 12 |
#3 | Tanis Steven P | 11 |
#4 | Larsen Scott D | 11 |
#5 | Gadwood Robert C | 6 |
#6 | Parker Timothy | 6 |
#7 | Zeller James R | 3 |
#8 | Parker Tim | 2 |
#9 | Gadwood Robert | 1 |
#10 | Naik Tushar Anil | 1 |
Publication | Filing date | Title |
---|---|---|
WO2011133611A1 | Thiazolidinedione analogues | |
WO2011017244A1 | Polymorphs of 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)-1,3-thiazolidine-2,4-dione (mitoglitazone) | |
WO2010105048A1 | Thiazolidinedione analogues | |
CA2699289A1 | Thiazolidinedione analogues for the treatment of hypertension |